An Oral Revolution in Treating Adults Diagnosed with Type II Diabetes Mellitus

2 years ago

By: Samia Rahman Adity, PharmD Candidate c/o 2025 Diabetes Facts and Statistics Type II diabetes (T2D) has been a consequential…

FDA Approves Jardiance® for the Treatment of Adults with Chronic Kidney Disease

2 years ago

By: Urooj K. Malik, PharmD Candidate c/o 2024 Effective September 22, 2023, the United States (U.S.) Food and Drug Administration…

Rho Chi Talks: Interview with the CEO of Cullinan Oncology

2 years ago

Featuring: Nadim Ahmed, President and CEO, Cullinan Oncology By: Sairah Skeikh, PharmD Candidate c/o 2024 Nadim Ahmed is the President…

From Pharmacy Student to Pharmacist: A Breakdown of Expenses

2 years ago

By: Carolina Vargas, PharmD Candidate c/o 2024, Zoha Khalid, PharmD Candidate c/o 2024, and Nashfa Zaman, PharmD Candidate c/o 2024…

The New “Zombie Drug”

3 years ago

By: Sandra Jojo, PharmD Canddiate c/o 2024 The United States (US) is in the midst of an opioid overdose epidemic.…

Rho Chi Talks: A Peek Into Merck’s Division of Regulatory Affairs

3 years ago

Featuring: Janelle Derbis, PharmD By: Serina Lin, PharmD Candidate c/o 2024 Janelle Derbis is a PharmD graduate of Drake University,…

A Pharmacist’s Guide to Renal Transplant Therapeutics and Allograft Rejection

3 years ago

By: Omar Elhoriny, PharmD Candidate c/o 2024 and Nancy Yousry, PharmD Candidate c/o 2024 The therapeutic space of solid organ…

RSV Vaccine: Furthering the Expansion of the Pharmacist’s Role

3 years ago

By: Ashley Medina, PharmD Candidate c/o 2025 After decades of trial and error, science is ready to offer preventative measures…

FDA Approves First Nonprescription Oral Contraceptive

3 years ago

By: Bhojranie Brahmanand, PharmD Candidate c/o 2025 Traditionally, a prescription has always been required for contraceptives such as birth control.…

Genetic Variants and its Link to Individuals Asymptomatic to COVID-19

3 years ago

By: Ariella Zadrima, PharmD Candidate c/o 2026 Since coronavirus disease 2019 (COVID-19) first made its appearance in December of 2019,…